Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,851 | 6,038 | 6,401 | 12,745 | 13,328 |
| Operating Income | -4,851 | -6,038 | -6,401 | -12,745 | -13,328 |
| Other Income | 407 | 590 | -203 | 10,455 | -1,337 |
| Pre-tax Income | -4,444 | -5,448 | -6,604 | -2,289 | -14,665 |
| Net Income Continuous | -4,444 | -5,448 | -6,604 | -2,355 | -14,665 |
| Net Income | $-4,444 | $-5,448 | $-6,604 | $-2,355 | $-14,665 |
| EPS Basic Total Ops | -1.41 | -3.39 | -4.20 | 2.64 | -11.18 |
| EPS Basic Continuous Ops | -1.41 | -3.39 | -4.30 | 2.66 | -11.18 |
| EPS Diluted Total Ops | -1.41 | -3.39 | -4.20 | 2.85 | -12.13 |
| EPS Diluted Continuous Ops | -1.41 | -3.39 | -4.30 | 3.01 | -11.06 |
| EPS Diluted Before Non-Recurring Items | -1.41 | -3.39 | -3.90 | -0.30 | -16.52 |
| EBITDA(a) | $-4,798 | $-5,982 | $-6,345 | $-12,676 | $-13,259 |